Cup-like acute myeloid leukemia: New disease or artificial phenomenon?

Haematologica

Volumn 93, Issue 2, 2008, Pages 283-286

  Kroschinsky, Frank P ^a   Schäkel, Ulrike ^a   Fischer, Rainer ^a   Mohr, Brigitte ^a   Oelschlaegel, Uta ^a   Repp, Roland ^b   Schaich, Markus ^a   Soucek, Silke ^a   Baretton, Gustavo ^a   Ehninger, Gerhard ^a   Thiede, Christian ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Acute myeloid leukemia; Cup like; FLT3; Morphology; NPM1

Indexed keywords

CD34 ANTIBODY; HLA D ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT;

ADULT; ANTIGENS, CD34; BLAST CRISIS; CELL NUCLEUS; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION REGULATION, LEUKEMIC; HLA-DR ANTIGENS; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; RANDOM ALLOCATION; SEX FACTORS;

EID: 40849089228     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11669     Document Type: Article

References (11)

1. Mrózek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007;109:431-48.
2. Kussick SJ, Stirewalt DL, Yi HS, Sheets KM, Pogosova-Agadjanyan E, Braswell S, et al. A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication. Leukemia 2004;18:1591-8.
3. Chen W, Rassidakis GZ, Li J, Routbort M, Jones D, Kantarjian H, et al. High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei). Blood 2006;108:1783-4.
4. Thiede C, Steudel C, Mohr B, Schaich M, Schäkel U, Platzbecker U, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002;99:4326-35.
5. Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, Schaich M, Ehninger G for the Deutsche Studieninitiative Leukämie (DSIL). Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 2006;107:4011-20.
6. Schaich M, Ritter M, Illmer T, Lisske P, Thiede C, Schäkel U, et al. Mutations in ras proto-oncogenesare associated with lower mdr1 gene expression in adult acute myeloid leukaemia. Br J Haematol 2001; 112:300-7.
7. Repp R, Schaekel U, Helm G, Thiede C, Soucek S, Pascheberg U, et al. and the AML-SHG Study Group. Immunophenotyping is an independent factor for risk stratification in AML. Cytometry B Clin Cytom 2003; 53:11-19.
8. Steudel C, Wermke M, Schaich M, Schäkel U, Illmer T, Ehninger G, Thiede C. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes Chromosomes Cancer 2003; 37:237-51.
9. Thiede C, Creutzig E, Illmer T, Schaich M, Heise V, Ehninger G, et al. Rapid and sensitive typing of NPM1 mutations using LNA-mediated PCR clamping. Leukemia 2006; 20:1897-9.
10. Olins AL, Olins DE. Cytoskeletal influences on nuclear shape in granulocytic HL-60 cells. BMC Cell Biol 2004;5:30-48.
11. Falini B, Nicoletti I, Martelli MF, Mecucci C. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood 2007; 109:874-85.